Inventor
KANEKIYO MASARU
US29 patents
⚠️ This page may combine multiple inventors who share the name “KANEKIYO MASARU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
19 patentsUS10301377B2May 28, 2019
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
US HEALTH24 citations93
US10017543B2Jul 10, 2018
Prefusion RSV F proteins and their use
US HEALTH26 citations92
US10960070B2Mar 30, 2021
Prefusion coronavirus spike proteins and their use
US HEALTH25 citations90
US10961283B2Mar 30, 2021
Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
US HEALTH11 citations83
US10363301B2Jul 30, 2019
Stabilized influenza hemagglutinin stem region trimers and uses thereof
US HEALTH5 citations83
US10137190B2Nov 27, 2018
Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteins
US HEALTH10 citations82
US11939356B2Mar 26, 2024
Self-assembling insect ferritin nanoparticles
US HEALTH2 citations71
US11130785B2Sep 28, 2021
Prefusion RSV F proteins and their use
US HEALTH2 citations71
US11793871B2Oct 24, 2023
Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
US HEALTH2 citations70
US12268737B2Apr 8, 2025
Stabilized influenza hemagglutinin stem region trimers and uses thereof
US HEALTH0 citations62
US11969466B2Apr 30, 2024
Stabilized influenza hemagglutinin stem region trimers and uses thereof
US HEALTH0 citations62
US11938221B2Mar 26, 2024
Multivalent nanoparticle-based vaccines
US HEALTH0 citations62
US12410240B2Sep 9, 2025
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
US HEALTH0 citations61
US11981707B2May 14, 2024
Prefusion RSV F proteins and their use
US HEALTH0 citations61
US11926656B2Mar 12, 2024
Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infection
US HEALTH0 citations61
US12527857B2Jan 20, 2026
Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
US HEALTH0 citations59
US11964010B2Apr 23, 2024
Prefusion coronavirus spike proteins and their use
US HEALTH0 citations58
US10759846B2Sep 1, 2020
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
US HEALTH0 citations51
US12084489B2Sep 10, 2024
Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection
US HEALTH0 citations50
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES
5 patentsUS11147867B2Oct 19, 2021
Stabilized influenza hemagglutinin stem region trimers and uses thereof
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES1 citations72
US11679151B2Jun 20, 2023
Stabilized influenza hemagglutinin stem region trimers and uses thereof
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES0 citations61
US11236151B2Feb 1, 2022
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES0 citations61
US11191727B2Dec 7, 2021
Multivalent nanoparticle-based vaccines
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES1 citations61
US12433943B2Oct 7, 2025
Nanoparticle-based influenza virus vaccines and uses thereof
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES0 citations56
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES
3 patentsUS11338033B2May 24, 2022
Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES5 citations81
US10744199B2Aug 18, 2020
Epstein-Barr virus vaccines
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES4 citations71
US12005115B2Jun 11, 2024
Epstein-barr virus vaccines
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES0 citations61